Rankings
▼
Calendar
BMY Q2 2016 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena
BMY
Bristol-Myers Squibb Company
$120B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$4.9B
Gross Profit
$3.7B
75.2% margin
Operating Income
$1.1B
23.3% margin
Net Income
$1.2B
23.9% margin
EPS (Diluted)
$0.69
QoQ Revenue Growth
+10.9%
Cash Flow
Operating Cash Flow
$439M
Free Cash Flow
$178M
Stock-Based Comp.
$54M
Balance Sheet
Total Assets
$32.8B
Total Liabilities
$17.8B
Stockholders' Equity
$14.9B
Cash & Equivalents
$2.9B
Revenue Segments
Opdivo
$840M
17%
Eliquis
$777M
16%
Orencia
$593M
12%
Hepatitis C Portfolio
$546M
11%
Mature Products And All Other
$537M
11%
Sprycel
$451M
9%
Baraclude
$299M
6%
Sustiva Franchise
$271M
6%
Reyataz
$247M
5%
Yervoy
$241M
5%
Abilify
$35M
1%
Empliciti
$34M
1%
← FY 2016
All Quarters
Q3 2016 →
